Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer

Reproductive Techniques Clinical Trial

Official title:

Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04261660
• Other study ID #: CMC-19-0161-CTIL
• Status: Not yet recruiting
• Start date: March 1, 2020
• Est. completion date: April 1, 2021

Study information

• Verified date: February 2020
• Source: Carmel Medical Center
• Contact: ido Fefekorn, MD
• Phone: +972-54-3537401
• Email: idofe[@]clalit.org.il
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Assessing the relationship between the VEGF levels in blood and the IVF protocol

Description:

The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 90
• Est. completion date: April 1, 2021
• Est. primary completion date: March 1, 2021
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

Patients undergoing IVF -

Exclusion Criteria:

• Women with any malignancy

• Patients request to be withdrawn

Related Conditions & MeSH terms

• Reproductive Techniques

Intervention

Other:
• NO intervention
NO INTERVENTION

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Carmel Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	vascular endothelial growth factor LEVELS	levels of vascular endothelial growth factor in blood	5 days